Diabetic retinopathy is a complication of diabetes that damages the blood vessels in the retina, leading to vision loss.
The symptoms of diabetic retinopathy are not always apparent, which is why regular screening is essential.
Using advanced technology, our painless and accurate screening aims to detect the early signs of retinopathy, allowing for early intervention to prevent serious visual complications.
At the forefront of innovation, APSA uses the NFC-700 digital retinal camera, equipped with an artificial intelligence (AI)-based interpretation system.
This enables autonomous detection of diabetic retinopathy, tested on over half a million patients worldwide.
A camera ten times more effective than conventional equipment for retinopathy screening:
For more information, speak to our doctors or contact us at 467 5858 or 136. 📞